Abbott ABT Incentive stock program, shares reserved for future grants (in shares)

Incentive stock program, shares reserved for future grants (in shares) at other companies

Merck & Co.MRK

——

West Pharmaceutical ServicesWST

——

Other financials

Income statement

See full

Revenue$11.2B+7.8%

Gross profit$6.3B+6.5%

Operating income$1.3B-20.6%

Net income$1.1B-18.7%

EPS (diluted)$0.61-19.7%

Balance sheet

See full

Cash & equivalents$6.8B+4.2%

Total debt$34.0B+157%

Total equity$52.1B+6.7%

Total assets$110.43B+35.6%

Cash flow

See full

Operating cash flow$1.3B-7.2%

CapEx$399.0M-17.6%

Free cash flow$916.0M-1.8%

Valuation

See full

Market cap$154.15B-22.5%

Enterprise value$181.39B-13.1%

P/E24.6×+9.8×

P/S3.4×-1.3×

Profitability

See full

Gross margin56.3%+0.4pp

Operating margin17.1%+0.2pp

Net margin13.9%-18.0pp

Returns & leverage

See full

Return on equity12.4%-18.4pp

Debt / equity0.7×+0.4×

Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's incentive stock program, shares reserved for future grants (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Abbott's incentive stock program, shares reserved for future grants (in shares)?: Abbott (ABT) reported incentive stock program, shares reserved for future grants (in shares) of 37M in Q1 2026.
How has Abbott's incentive stock program, shares reserved for future grants (in shares) changed year-over-year?: Abbott's incentive stock program, shares reserved for future grants (in shares) decreased by 26.0% year-over-year, from 50M to 37M.